Venus Medtech (Hangzhou), Inc. Class H (2500) Financial Statements

Venus Medtech (Hangzhou), Inc. Class H's market cap is currently HK$1.16B. The company's EPS TTM is HK$-1.258; its P/E ratio is ―; Venus Medtech (Hangzhou), Inc. Class H is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.